SCHEMBL4184360

SCHEMBL4184360

O=CCC(=O)N1CCN(C(=O)O)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
HSD17B10 Q99714 2/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
USP2 O75604 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
GAA P10253 1/20 0.35
ATM Q13315 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
POLB P06746 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203722 0.81 ATM (0.52) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL3082371 0.81 ATM (0.52) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL3949996 0.80 CYP1A2 (0.48) KMT2ATDP1MAPTSMN1; SMN2POLB
SCHEMBL8185942 0.80 CYP1A2 (0.48) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL27396631 0.79 ATM (0.50) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL30455653 0.76 CA2 (0.45) KMT2AGAAPOLBHSD11B1
SCHEMBL3582413 0.76 L3MBTL1 (0.55) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL3955618 0.75 TP53 (0.53) ALDH1A1LMNAHPGDTDP1TSHR
SCHEMBL16904 0.74 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AHSD17B10LMNA
SCHEMBL9079929 0.74 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029375-A1 NOVEL INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-03-05 WO disclosed